Insider Trading & Ownership of Anne Clem Whitaker

Location
Morrisville, NC
Summary
The estimated net worth of Anne Clem Whitaker is at least $741,221 dollars as of 18 Mar 2026. Anne Clem Whitaker is the Director of CALADRIUS BIOSCIENCES, INC. and owns shares of LISATA THERAPEUTICS, INC. (LSTA) stock worth about $546.1K. Anne Clem Whitaker is the Director of ORASURE TECHNOLOGIES INC and owns shares of ORASURE TECHNOLOGIES INC (OSUR) stock worth about $195.1K.
Signature
/s/ Erina Joan Fox, as Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Anne Clem Whitaker and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Quick Takeaways

  • Anne Clem Whitaker has 4 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $741,221.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: CALADRIUS BIOSCIENCES, INC. ($546,079).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Anne Clem Whitaker

ICLR Forms 3/4/5

ICON PLC

Relationship
Director
Holdings value
Past year net change
Change %
Report period
18 Mar 2026
MNKPF Forms 3/4/5

Mallinckrodt plc

Relationship
Director
Holdings value
Past year net change
Change %
Report period
16 Jun 2022

Insider Transactions Reported by Anne Clem Whitaker:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .